Furthermore, CXCR2 has been identified as an adverse prognostic factor for MDS/AML, suggesting that the CXCL8/CXCR2 axis likely plays a crucial role in AML/MDS. This evidence concerns the gene CXCR2 and acute myeloid leukemia.